Dichloroacetate (DCA) is a small-molecule compound that has gained attention for its potential use in cancer treatment. It is a salt form of dichloroacetic acid and has been primarily used to treat metabolic disorders such as congenital lactic acidosis. Its mechanism of action involves the inhibition of the enzyme pyruvate dehydrogenase kinase (PDK), which plays a significant role in cellular metabolism.
